Form 8 (DD) – Steven Gillis
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR […]
Unum Therapeutics Added to NASDAQ Biotechnology Index
CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) — Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the […]
Form 8 (DD) – Susan Kilsby
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR […]
Lexicon Pharmaceuticals Announces Topline Phase 1 Clinical Results for LX2761 in Diabetes
THE WOODLANDS, Texas, Dec. 20, 2018 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced topline results from Phase […]
iCAD, Inc. Announces $7.0 Million Private Placement of Unsecured Subordinated Convertible Debentures
Added Funds to support global commercialization of cancer detection capability and cancer therapy technology NASHUA, N.H., Dec. 20, 2018 (GLOBE […]
Form 8 (DD) – Olivier Bohuon
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR […]
Rosehill Resources Inc. Provides 2019 Guidance Along With Operational Update
HOUSTON, Dec. 20, 2018 (GLOBE NEWSWIRE) — Rosehill Resources Inc. (“Rosehill” or the “Company”) (NASDAQ: ROSE, ROSEW, ROSEU) today announced […]
Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults
DUBLIN, Ireland, Dec. 20, 2018 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the […]
The Tile Shop Names Cabell Lolmaugh as Director and CEO
MINNEAPOLIS, Dec. 20, 2018 (GLOBE NEWSWIRE) — Tile Shop Holdings, Inc. (Nasdaq: TTS) (the “Company”), a specialty retailer of natural […]
Apellis Pharmaceuticals Provides Update on Its Phase 3 Program for Patients with Geographic Atrophy
Phase 3 geographic atrophy program enrollment timeline currently unchanged; program enrollment is expected to restart in Q2 2019 and enrollment […]
